Psychotic behaviour represents episodes where a person temporarily loses connection with reality, experiencing symptoms that can be frightening and confusing. While these episodes may seem overwhelming, a range of treatment approaches—from established medications to emerging therapies being tested in research settings—offers hope for managing symptoms and improving quality of life.

Understanding Treatment Goals and Options for Psychotic Episodes

When someone experiences psychotic behaviour, which means they have difficulty distinguishing what is real from what is not, the primary goal of treatment is to help them reconnect with reality and reduce distressing symptoms. Treatment approaches focus on relieving symptoms like hearing voices that aren’t there or holding beliefs that others don’t share, while also working to improve the person’s ability to function in daily life, maintain relationships, and participate in work or education.^[1]

The specific treatment plan depends heavily on what is causing the psychotic symptoms and how severe they are. Because psychotic behaviour can stem from various underlying conditions—including schizophrenia, bipolar disorder, severe depression, medical illnesses affecting the brain, or substance use—healthcare professionals must first identify the root cause through careful evaluation.^[2] This means that two people experiencing similar symptoms might receive quite different treatment plans based on their individual circumstances.

Modern treatment guidelines recommend combining several approaches rather than relying on just one method. Medical societies and healthcare organizations generally suggest using antipsychotic medications as a foundation, supported by talking therapies and practical social support to help with housing, employment, and daily functioning.^[3] At the same time, researchers continue investigating new treatments through clinical trials, searching for options that might work better, cause fewer side effects, or help people who haven’t responded to standard approaches.

The timing of treatment matters significantly. Starting treatment as soon as possible after psychotic symptoms appear—particularly during a first episode—can lead to better long-term outcomes. Early intervention teams, which are specialized groups of healthcare professionals trained to work with people experiencing their first psychotic episode, have shown promising results in helping individuals recover more quickly and completely.^[8]

Standard Treatment Approaches for Psychotic Behaviour

The cornerstone of treating psychotic behaviour involves antipsychotic medications, which are drugs specifically designed to reduce or eliminate symptoms like hallucinations and delusions. These medications work by affecting chemical messengers in the brain called neurotransmitters, particularly one called dopamine. By blocking certain receptors that respond to dopamine, these drugs help restore more normal brain function and reduce the intensity of psychotic experiences.^[8]

Antipsychotic medications fall into two main categories. First-generation antipsychotics, also called typical antipsychotics, have been used since the 1950s and include drugs like haloperidol, chlorpromazine, and perphenazine. Second-generation antipsychotics, sometimes called atypical antipsychotics, are newer medications that include drugs like olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, and paliperidone. Medical guidelines generally recommend starting with second-generation antipsychotics because they tend to cause fewer movement-related side effects compared to older medications.^[13]

These medications can be taken in different forms depending on the situation. Most commonly, people take them as pills or liquid by mouth each day. For some individuals who have difficulty remembering daily medications or who prefer less frequent dosing, long-acting injectable versions are available that only need to be given every one to four weeks.^[8] When someone is experiencing an acute, severe episode and needs rapid relief, doctors may use injectable forms that work quickly to calm agitation and reduce frightening symptoms.

The effects of antipsychotic medications develop at different speeds depending on which symptoms they’re targeting. Many people notice reduced anxiety and agitation within hours of taking the first dose. However, the core psychotic symptoms—the hallucinations and delusional beliefs—typically take longer to improve, often requiring several days or weeks of consistent medication use before significant relief occurs.^[8] This delay means patients and their families need patience and ongoing support during the initial treatment period.

While antipsychotic medications can be very helpful, they also come with potential side effects that vary from person to person. Common side effects include feeling drowsy or tired, experiencing trembling or shaking in the hands, gaining weight, feeling restless and unable to sit still, and experiencing muscle twitches or spasms. Some people develop blurred vision, dizziness, constipation, or notice changes in their interest in sex. A dry mouth is another frequent complaint.^[8] These side effects don’t affect everyone equally—some people experience many side effects while others have very few.

If side effects become troublesome, it’s crucial not to simply stop taking the medication without medical guidance. Stopping antipsychotic medications suddenly can trigger a return of psychotic symptoms, sometimes even more severe than before. Instead, doctors can often adjust the dose, switch to a different antipsychotic that might cause fewer problems for that particular person, or add other medications to counteract specific side effects like movement problems.^[8]

The duration of treatment varies considerably depending on the underlying cause of the psychotic behaviour. For brief psychotic episodes triggered by extreme stress, where symptoms developed quickly and a clear stressor can be identified, treatment might be quite short—sometimes just removing the stressful situation is enough. If medication is needed, it might only be prescribed for up to one month.^[13] However, for people with ongoing conditions like schizophrenia, long-term medication treatment is usually necessary, sometimes continuing for years or even a lifetime to prevent symptom recurrence.

Talking Therapies and Psychological Support

Cognitive behavioural therapy, often shortened to CBT, is a type of talking therapy specifically adapted for people experiencing psychotic symptoms. This approach doesn’t focus on convincing someone that their unusual experiences aren’t real. Instead, it helps people understand how they interpret their experiences and why some interpretations cause more distress than others. A therapist might work with someone to consider alternative explanations for their experiences and develop coping strategies that reduce the anxiety and disruption caused by symptoms.^[8]

The goals of CBT for psychosis are practical and individualized. Therapists aim to help people achieve what matters most to them—whether that’s reducing distress, returning to work or school, reestablishing relationships, or regaining a sense of control over their lives. The therapy sessions provide a safe space to discuss frightening experiences without judgment and to gradually build confidence in distinguishing between helpful and unhelpful thoughts.

Family intervention represents another important component of comprehensive treatment. Psychotic episodes don’t just affect the person experiencing them—they also impact family members who often take on caregiving roles. Family therapy brings together the person experiencing psychosis and their close relatives for a series of meetings over several months. These sessions cover practical information about psychosis, how it might develop over time, and what treatments are available.^[8]

These family sessions also explore ways that relatives can best support their loved one without becoming overwhelmed themselves. Families work together to solve practical problems, such as developing plans for what to do if symptoms worsen or figuring out how to manage daily routines. This approach recognizes that caring for someone with psychotic behaviour can place significant strain on relationships and that supporting the whole family system leads to better outcomes for everyone involved.

Social Support and Rehabilitation

Beyond medication and therapy, practical social support plays a vital role in recovery. Many people experiencing psychotic behaviour face challenges with basic life activities—they might struggle to maintain employment, keep up with education, manage finances, or maintain stable housing. Social support services help address these fundamental needs, recognizing that having secure housing, meaningful daily activities, and financial stability contribute significantly to mental health recovery.^[3]

For people experiencing severe symptoms, hospitalization might be necessary temporarily. This doesn’t mean long-term institutional care—modern treatment emphasizes using hospitals only briefly during crisis periods when someone might be at risk of harming themselves or others. The goal is always to stabilize symptoms and return the person to their community as quickly and safely as possible.^[4]

Treatment in Clinical Trials: Exploring New Approaches

While standard treatments help many people, researchers recognize that current options don’t work well enough for everyone. Around one-third to potentially two-thirds of people with psychotic disorders show inadequate response to available antipsychotic medications.^[12] Similarly, psychological therapies, while helpful, produce only small to modest improvements in symptoms for many individuals. This reality drives ongoing research into new treatment approaches being tested in clinical trials.

Clinical trials investigating treatments for psychotic behaviour operate in phases, each designed to answer different questions. Phase I trials primarily test whether a new treatment is safe and what dose should be used. These early trials involve small numbers of participants and focus on identifying any harmful effects. Phase II trials expand to larger groups and begin examining whether the treatment actually improves symptoms—does it reduce hallucinations, lessen delusional thinking, or improve functioning? Phase III trials compare the new treatment directly against standard treatments to determine if the innovation offers meaningful advantages over what’s already available.

Innovative Medication Approaches

Researchers are investigating antipsychotic medications that work through different mechanisms than traditional options. While standard antipsychotics primarily block dopamine receptors, newer experimental drugs might target different neurotransmitter systems or affect multiple brain chemical pathways simultaneously. The hope is that these alternative mechanisms might help people who haven’t responded to conventional treatments or might cause fewer problematic side effects.

Some research focuses on medications that could address symptoms beyond hallucinations and delusions. Many people with psychotic disorders experience what are called negative symptoms—a decrease in normal functioning such as reduced emotional expression, lack of motivation, or social withdrawal. Standard antipsychotic medications often help less with these symptoms than with the more obvious hallucinations and delusions. Clinical trials are testing whether new drugs or combinations of medications might better address these challenging negative symptoms that significantly impact quality of life.^[12]

Advanced Technology-Based Interventions

An exciting area of research involves combining traditional psychotherapy with modern technology and neuroscience advances. Some clinical trials explore whether using smartphone apps or digital platforms can enhance therapy outcomes. These technologies might help people practice coping strategies in real-time when symptoms occur, track their experiences more accurately, or maintain more consistent connection with their treatment team between appointments.

Researchers are also investigating whether techniques like neurofeedback—where people learn to modify their own brain activity patterns through real-time feedback from brain monitoring equipment—might help reduce psychotic symptoms. These approaches represent a fundamentally different strategy from simply taking medication, instead teaching people skills to directly influence their brain function.^[12]

Addressing Social Disconnection

Recent research increasingly recognizes that social isolation and loneliness significantly worsen outcomes for people with psychotic disorders. Clinical trials are testing interventions specifically designed to reduce social disconnection and rebuild meaningful relationships. These might include structured social skills training programs, peer support groups facilitated through online platforms, or therapeutic approaches that explicitly target the social aspects of recovery rather than just symptom reduction.^[12]

Some trials focus on what researchers call “hot cognitions”—thoughts and beliefs that carry strong emotional significance. Rather than treating all unusual thoughts equally, these approaches recognize that some beliefs matter more to people than others and cause more distress. By targeting the specific thoughts that most interfere with someone’s life and wellbeing, these therapies might achieve better results than more general approaches.

Rapid Treatment Options

For people experiencing acute psychotic crises, researchers are testing rapidly-acting treatments that could provide relief faster than traditional approaches. For example, clinical trials have examined whether certain antipsychotic medications given by injection can calm severe agitation and reduce frightening symptoms more quickly and safely than older options. One study found that intramuscular ziprasidone was more effective and better tolerated than intramuscular haloperidol for treating acute psychosis.^[13] These rapid-acting options could make crisis situations safer and less traumatic for both patients and their families.

Eligibility and Locations for Clinical Trials

Clinical trials for psychotic behaviour typically have specific criteria for who can participate. Eligibility often depends on factors like the type of psychotic symptoms experienced, whether this is a first episode or recurrent condition, age, other health conditions, and current medications. Some trials specifically seek people who haven’t responded well to standard treatments, while others want participants who are experiencing their first episode and haven’t yet received extensive treatment.

Trials take place in various locations including the United States, Europe, and other regions worldwide. Major research institutions and universities often conduct these studies, sometimes in collaboration with specialized mental health clinics. Information about ongoing trials can typically be found through national clinical trial registries, mental health research organizations, and by discussing with mental health care providers who may know about local trial opportunities.^[1]

Most common treatment methods

• Antipsychotic medications
  • Second-generation antipsychotics like olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole, and paliperidone are generally recommended as first-line treatment
  • First-generation antipsychotics like haloperidol, chlorpromazine, and perphenazine are used as second-line options
  • Available in oral forms taken daily or long-acting injectable forms given every 1-4 weeks
  • Work by blocking dopamine receptors in the brain to reduce hallucinations and delusions
  • May take several days to weeks to show full effect on psychotic symptoms
• Cognitive behavioural therapy (CBT)
  • Talking therapy adapted specifically for psychotic symptoms
  • Helps people understand their experiences and develop coping strategies
  • Focuses on reducing distress and improving functioning rather than just eliminating symptoms
  • Works on identifying alternative explanations for unusual experiences
• Family intervention
  • Involves family members in series of therapy sessions over 3 months or more
  • Provides education about psychosis and available treatments
  • Develops strategies for family members to support their loved one
  • Addresses practical problem-solving for managing symptoms and crises
• Social support services
  • Assistance with housing stability and accommodation needs
  • Support for maintaining or returning to employment
  • Help with continuing education or training programs
  • Practical daily living support and skills training
• Crisis intervention and hospitalization
  • Brief hospital stays during severe episodes when safety is a concern
  • Rapid stabilization with injectable medications if needed
  • Intensive monitoring and support until acute symptoms improve
  • Goal of returning to community care as quickly as safely possible